Nauchno-Prakticheskaya Revmatologiya

Aims & Scope

The scientific journal Nauchno-Prakticheskaya Revmatologiya is included in the Scopus database.

Publisher country is RU.

The main subject areas of published articles are Immunology, Immunology and Allergy, Rheumatology, Клиническая медицина.

We offer making basic requirements to academic papers compliance test using "Paper quality checking" service.

Paper quality checking service is in demand among researchers who wish to make final improvements to their work before submitting it to the target journal.The experienced editors of ORES, who have published papers in cited journals, with the participation of foreign partners go through finished articles.

They perform complex checks on many parameters, improve the structure and logic of content, and conduct spell checks, among others.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology and Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES

  Citation: 135

  Authors: A. E., E. L., V. T., A. I., N. N., G. P., L. I., G. R., M. A., M. L., S. S., A. M., T. L., D. S., T. V., A. P., K. V., N. V.

• SF-36 questionnaire population quality of life indices Objective

  Citation: 62

  Authors: V N, D V, N I, A P, V N

• RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE

  Citation: 57

  Authors: E. L., Yu. A., A. M.

• PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: NEW STRATEGY, NEW TARGETS

  Citation: 51

  Authors: E. L.

• Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects

  Citation: 50

  Authors: E. L., A. M.

• ON THE TERMINOLOGY OF SPONDYLOARTHRITIS

  Citation: 49

  Authors: Sh. F., V. V., A. G., O. V., I. Z., A. A., A. A., T. V., O. N., T. V., S. A., O. B., I. P., E. N., T. A., A. P., O. A., A. V., A. V.

• INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES

  Citation: 49

  Authors: E. L., A. M.

• CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS

  Citation: 49

  Authors: E. L.

• Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia

  Citation: 48

  Authors: E. L., A. M., V. I., B. S., A. E., T. V., O. A., A. A., D. I., S. V., A. I.

• ROLE OF INTERLEUKIN 1 IN THE DEVELOPMENT OF HUMAN DISEASES

  Citation: 44

  Authors: E. L., M. S.